Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells
- PMID: 2676191
- DOI: 10.1016/0092-8674(89)90873-8
Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells
Abstract
The unprocessed Gag precursor from HIV-1, when expressed in recombinant baculovirus-infected insect cells, is targeted to the plasma membrane and assembles in 100-120 nm particles budding from the cell surface. This process mimics HIV immature particle formation and is dependent on myristoylation of the N-terminal glycine, as deletion of the latter results in particle accumulation in the cytoplasm and, interestingly, in the nucleus, pointing to a potential role of this non-fatty-acid-acylated species in the viral life cycle. Inclusion of the pol gene in the construct results in efficient processing of Pr55gag and a pronounced decrease in particle formation. Deletion of the C terminus (p16) of the Gag precursor, including the finger domains, abolishes particle assembly, but membrane targeting and evagination still occur. Heterologous expression in insect cells may prove very useful for the study of the molecular events leading to retroviral particle morphogenesis.
Similar articles
-
Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.Arch Virol. 1992;127(1-4):117-37. doi: 10.1007/BF01309579. Arch Virol. 1992. PMID: 1456888
-
Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.J Virol. 1994 Jan;68(1):111-22. doi: 10.1128/JVI.68.1.111-122.1994. J Virol. 1994. PMID: 8254720 Free PMC article.
-
The GAG precursor of simian immunodeficiency virus assembles into virus-like particles.EMBO J. 1989 Sep;8(9):2653-60. doi: 10.1002/j.1460-2075.1989.tb08405.x. EMBO J. 1989. PMID: 2684654 Free PMC article.
-
Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing.J Gen Virol. 2001 Nov;82(Pt 11):2719-2733. doi: 10.1099/0022-1317-82-11-2719. J Gen Virol. 2001. PMID: 11602784
-
Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins.J Gen Virol. 1998 May;79 ( Pt 5):1069-81. doi: 10.1099/0022-1317-79-5-1069. J Gen Virol. 1998. PMID: 9603321
Cited by
-
EXTL3 and NPC1 are mammalian host factors for Autographa californica multiple nucleopolyhedrovirus infection.Nat Commun. 2024 Sep 4;15(1):7711. doi: 10.1038/s41467-024-52193-w. Nat Commun. 2024. PMID: 39231976 Free PMC article.
-
Efficient production of HIV-1 virus-like particles from a mammalian expression vector requires the N-terminal capsid domain.PLoS One. 2011;6(11):e28314. doi: 10.1371/journal.pone.0028314. Epub 2011 Nov 30. PLoS One. 2011. PMID: 22140574 Free PMC article.
-
Assembly and architecture of HIV.Adv Exp Med Biol. 2012;726:441-65. doi: 10.1007/978-1-4614-0980-9_20. Adv Exp Med Biol. 2012. PMID: 22297526 Free PMC article. Review.
-
Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine.J Virol. 1992 Jul;66(7):4003-12. doi: 10.1128/JVI.66.7.4003-4012.1992. J Virol. 1992. PMID: 1602531 Free PMC article.
-
Spike protein-nucleocapsid interactions drive the budding of alphaviruses.J Virol. 1992 Aug;66(8):4737-47. doi: 10.1128/JVI.66.8.4737-4747.1992. J Virol. 1992. PMID: 1629953 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
